Assessment of Patient-Reported Goal Attainment in the Treatment of Female Overactive Bladder (Phase IV).
Phase of Trial: Phase IV
Latest Information Update: 29 May 2013
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Dec 2011 Planned End Date changed from 1 Nov 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 11 Feb 2009 New trial record